MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 113 filers reported holding MERSANA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,166,161 | +20.4% | 962,359 | +50.4% | 0.02% | +109.1% |
| Q1 2023 | $2,630,400 | +63.2% | 640,000 | +132.7% | 0.01% | -31.2% |
| Q4 2022 | $1,611,500 | -2.7% | 275,000 | +12.2% | 0.02% | +6.7% |
| Q3 2022 | $1,656,000 | -10.4% | 245,000 | -38.8% | 0.02% | +7.1% |
| Q2 2022 | $1,848,000 | +6.5% | 400,000 | -8.0% | 0.01% | -39.1% |
| Q1 2022 | $1,736,000 | -3.8% | 435,000 | +50.0% | 0.02% | +27.8% |
| Q4 2021 | $1,804,000 | +9.3% | 290,000 | +65.7% | 0.02% | -18.2% |
| Q3 2021 | $1,650,000 | +73.5% | 175,000 | +150.0% | 0.02% | +100.0% |
| Q2 2021 | $951,000 | – | 70,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |